← Health at Work
HEALTH AT WORK
Industrial Health

Occupational Asthma: Causes, Symptoms and Prevention at Work

15 August 2026 · Health at Work · Reviewed by Dr. Ackhmez Chuttoo, MD

Photo: Tima Miroshnichenko / Pexels

Occupational asthma is one of the most common work-related lung diseases in the world, yet it remains widely underdiagnosed and underreported. The gap between first exposure and confirmed diagnosis is often measured in years — and during that time, irreversible airway remodelling can occur. This is not a condition that simply improves with medication if the exposure continues. For many workers, the trajectory ends in permanent respiratory disability and a forced change of career. Employers and occupational health professionals carry a specific, preventable burden here: the damage is predictable, the causes are known, and the controls exist. Acting late is not a neutral choice.

What Occupational Asthma Actually Is — and Why It Differs From Other Asthma

Occupational asthma is not simply pre-existing asthma made worse by a dusty environment. It is asthma that is directly caused by workplace exposures, through one of two distinct biological mechanisms — and understanding which mechanism is at work determines how urgently the situation must be treated.

The first and more common mechanism is sensitisation. When a worker repeatedly inhales a respiratory sensitiser — a substance capable of triggering an immune response — the immune system eventually identifies it as a threat and mounts an inflammatory reaction in the airways. The critical and dangerous feature of sensitisation is that once it has occurred, even tiny amounts of the substance — far below any exposure limit — can trigger a severe asthma attack. There is no safe threshold after sensitisation. This is why early removal from exposure is the only medically sound response.

The second mechanism is irritant-induced asthma, formally called Reactive Airways Dysfunction Syndrome (RADS). This results from a single, high-level exposure to a corrosive or toxic substance — a chemical spill, an accidental release of chlorine gas, a confined-space fumigation that goes wrong. The airways sustain direct chemical injury and become permanently hyperreactive. RADS does not require a period of sensitisation and can affect any worker caught in the incident, regardless of prior respiratory health.

Both types are genuinely occupational in origin. Both can result in permanent impairment. The distinction matters because sensitiser-induced asthma demands long-term surveillance of all exposed workers, not just the one who has become ill.

Which Jobs and Tasks Carry Real Risk

Risk is not evenly distributed across industries. Certain jobs concentrate exposure in ways that make sensitisation substantially more likely, particularly where processes generate fine aerosols, dusts or vapours that remain airborne and are inhaled repeatedly over a working day.

Spray painters in automotive bodyshops face some of the highest documented rates of occupational asthma of any occupation. The isocyanates in two-pack polyurethane paints are potent sensitisers, and spray application generates aerosol particles small enough to penetrate deep into the lungs. A worker who applies paint in a booth that is inadequately ventilated, or who enters a freshly sprayed area too soon, is receiving exactly the kind of repeated low-level exposure that leads to sensitisation — often without realising it until symptoms appear months or years later.

Bakers and pastry workers inhale flour dust during mixing, weighing and proving. The proteins in wheat and rye flour are well-established sensitisers, and amylase enzymes added to improve bread texture are even more potent. A baker who hand-weighs flour into a mixing bowl at bench height, without extraction, is generating a dust cloud directly at breathing zone level. The same applies to workers in animal feed mills, where grain dust and storage mite proteins compound the risk.

In healthcare, latex proteins from powdered examination gloves have caused significant occupational asthma in nurses, surgeons and laboratory staff. The powder on gloves acts as a carrier, becoming airborne when gloves are snapped on or removed. Many workplaces have moved to powder-free or non-latex gloves, but latex sensitisation can persist for the rest of a worker's career once established.

Hairdressers are exposed to persulfate salts in bleaching powders — a cause of asthma that is often overlooked. The exposure occurs during mixing and application, particularly in poorly ventilated salon areas. Cleaners face risks from bleach-based sprays and products containing quaternary ammonium compounds, especially when used in confined or unventilated spaces. Woodworkers handling hardwoods such as iroko, obeche and western red cedar encounter dusts with strong sensitising properties. Welding fume — generated whenever metal is joined — is a respiratory hazard in its own right, and chromium and nickel compounds in stainless steel welding fume are additionally carcinogenic.

Agricultural workers face organic dusts from grain, hay, animal dander and fungal spores, often in combination. The term 'farmers' lung' describes a specific hypersensitivity reaction, but general occupational asthma from agricultural dust is common and often attributed to seasonal allergies until a pattern of work-related worsening becomes undeniable.

What Early and Late Symptoms Look Like — Detail a Worker Can Recognise

The hallmark pattern of occupational asthma is temporal: symptoms improve when away from work and return or worsen when back. But this pattern is not always obvious to the person experiencing it, particularly in the early stages when symptoms are mild and intermittent.

Early symptoms tend to appear toward the end of a working shift or in the hours after leaving work — a dry, irritating cough that starts in the late afternoon or evening, mild chest tightness noticed while climbing stairs at the end of a working day, or a slightly breathless feeling on waking that clears through the morning. These are easy to attribute to a cold, hayfever or simply being unfit. A worker might notice that the cough disappears during a two-week holiday and assume they simply had a respiratory infection that resolved. It returns within days of going back to work.

As sensitisation progresses and exposure continues, the pattern becomes more pronounced. Wheezing becomes audible — a high-pitched sound during breathing, particularly on exhalation. Chest tightness can wake a worker in the early hours. Breathlessness occurs with less exertion than before. Some workers describe being unable to complete tasks they managed easily six months earlier. The nose and eyes are often involved — rhinitis and conjunctivitis are common accompanying features of sensitiser-induced asthma, and their presence alongside respiratory symptoms in a worker with known sensitiser exposure should prompt urgent referral.

Late-stage occupational asthma is a different picture. By this point, continued exposure has caused structural changes in the airway walls — thickening, scarring, loss of elasticity. Lung function testing shows irreversible obstruction. Symptoms occur even at home, during weekends and holidays, because the airways are now permanently damaged and hyperreactive regardless of current exposure. This stage is reached because diagnosis was missed or delayed, or because exposure continued after warning signs were ignored. It is clinically similar to severe chronic obstructive pulmonary disease and responds poorly to medication alone.

Any worker who reports two or more of the following — unexplained cough, wheezing, chest tightness, shortness of breath — that follow a work-related pattern should be referred for occupational health assessment promptly, not reassured and sent back to the same exposure.

What Employers Are Required to Do

Under typical occupational health regulations and established frameworks for managing workplace health risk, employers who use or generate respiratory sensitisers carry specific duties — not general encouragement to be careful, but structured obligations with defined components.

The first duty is to assess the risk. This means identifying which substances in the workplace are respiratory sensitisers or irritants, which tasks generate inhalable exposure, and which workers are affected. A risk assessment that lists a substance as 'present' without analysing the actual exposure route or intensity is not adequate. It should answer: who inhales what, in what quantity, for how long, and how often.

The second duty is to reduce exposure so far as is reasonably practicable, following the hierarchy of controls. This is not a discretionary aspiration. It means that if substitution is technically feasible, it must be considered before accepting that engineering controls are the best achievable. If engineering controls can reduce exposure to a level where respiratory protective equipment becomes a backup rather than a primary defence, they must be implemented and maintained.

The third duty is to implement health surveillance for workers exposed to known sensitisers. In most jurisdictions, health surveillance for respiratory sensitiser exposure is a legal requirement, not an optional benefit. It must be structured — not an annual question of 'are you feeling alright?' — and must include periodic lung function testing, symptom questionnaires reviewed by a competent occupational health professional, and a defined process for escalating concerns.

When a worker is found to have developed occupational asthma, the employer's duty is to act on that finding: remove the worker from further exposure, investigate whether other workers have been exposed to the same conditions, and review whether existing controls have failed. A single confirmed case is a sentinel event that implies a systemic control failure, not an individual misfortune.

Controls That Work — and Ones That Are Overestimated

The hierarchy of controls is not a list of equal options. It is a ranked system in which the most effective interventions remove or reduce the hazard at source, and the least effective ones rely on individual behaviour. Understanding where each measure actually sits in that hierarchy matters for making honest decisions about workplace safety.

Elimination — removing the sensitising substance from the process entirely — is the only measure that guarantees protection. It is not always possible, but it is more often feasible than employers initially assume. Water-borne paint systems have replaced isocyanate-based two-pack paints in many automotive refinishing operations without significant quality loss. Enzyme-free flour improvers have replaced certain amylase-containing additives in some bakery contexts. Where elimination is possible, it must be pursued.

Substitution means replacing a high-hazard substance with a lower-hazard one. Replacing powdered latex gloves with powder-free or synthetic alternatives is a substitution that has demonstrably reduced latex sensitisation rates in healthcare settings. Replacing a high-volatility solvent with a lower-volatility alternative reduces airborne concentration under the same conditions. Substitution is highly effective when the replacement is genuinely less hazardous — but it requires proper assessment of the substitute, not just an assumption that 'natural' or 'different' means safer.

Engineering controls — principally local exhaust ventilation (LEV) — are the backbone of exposure control in most industries where elimination and substitution are not fully achievable. A correctly designed and maintained LEV system captures contaminated air at or very close to the source, before it reaches the worker's breathing zone. The critical words are 'correctly designed' and 'maintained.' An LEV hood positioned 50 centimetres from the source is significantly less effective than one positioned at 10 centimetres. A system with a partially blocked duct or a fan running at reduced speed may look functional while providing a fraction of its rated capture efficiency. LEV systems require regular testing — in most jurisdictions at least annually — and records of that testing must be kept.

Enclosure of the process — putting the dust- or fume-generating task inside a contained space with its own ventilation — is more effective than open-floor LEV when it can be implemented. Automated or remote-controlled processes that remove the worker from the exposure zone entirely are more effective still.

Administrative controls include job rotation, limiting exposure time, and restricting access to high-exposure areas. These reduce the dose a given worker receives but do not reduce the concentration of the hazard itself. They have genuine value as part of a layered control strategy but are weak when used as a substitute for engineering measures. A worker who rotates through four different roles, each with some sensitiser exposure, may still accumulate enough cumulative dose to sensitise over time.

Respiratory protective equipment is the control measure most frequently overestimated. RPE does work when correctly selected, properly fitted and consistently worn — but each of those conditions is harder to guarantee than it appears. A half-face filtering facepiece respirator offers no protection if it does not seal against the wearer's face, if it is worn intermittently, if the filter is saturated or if the worker removes it during the highest-exposure moments of a task. Fit testing is not a one-time administrative step: it must be repeated when a worker's facial features change (weight gain or loss, dental work, scarring). RPE must never be the sole control measure for sensitiser exposure. Its role is to manage residual risk after higher-order controls have been applied.

What a Worker Should Do If They Are Already Affected

A worker who recognises the symptom pattern described above — cough, wheeze, chest tightness or breathlessness that follows a work-related rhythm — should act promptly rather than waiting to see if it resolves. The clinical evidence is consistent: the longer exposure continues after sensitisation, the worse the long-term outcome. Waiting is not a neutral decision; it is a decision to accept more damage.

The first step is to report symptoms to an occupational health service or, where that is not available, to a treating physician — with the specific information that symptoms improve away from work. This context is clinically important. Without it, a physician may treat the symptoms as non-occupational asthma and return the worker to the same exposure.

A diagnosis of occupational asthma should trigger a formal investigation into the exposure history: what substance, in what tasks, for how long, and whether engineering controls were in place and functioning. This is not simply an administrative exercise — it establishes the cause and determines whether other workers in the same environment are at risk.

If occupational asthma is confirmed, the worker should be redeployed away from exposure to the causative agent. This is not optional and is not adequately substituted by providing better RPE. Continued exposure after sensitisation, even at low levels, will cause progressive deterioration. Redeployment is difficult and often unwelcome — particularly for skilled tradespeople whose identity and income are bound up in their work — and this difficulty should be acknowledged directly. Structured support from an occupational health team, with clear and honest communication about the clinical reasons for the change, significantly improves acceptance and outcomes.

Workers should seek specialist respiratory assessment — not just a general practitioner appointment — when an occupational cause is suspected. Specific inhalation challenge testing, conducted under controlled clinical conditions, is the diagnostic gold standard for confirming sensitiser-induced occupational asthma when less invasive testing is inconclusive. Serial peak flow measurement — taking peak expiratory flow readings at regular intervals over several weeks, both at work and away from work — provides objective evidence of the work-related pattern and supports the clinical case.

What People Commonly Get Wrong About Occupational Asthma

The most consequential misunderstanding is that occupational asthma is a manageable condition that can be controlled by medication while exposure continues. It cannot. Inhalers reduce the severity of symptoms; they do not stop the progressive airway damage caused by repeated sensitiser exposure. A worker who is symptomatic, treated with a bronchodilator and returned to the same environment without exposure reduction is receiving treatment that masks a deteriorating condition. The airways continue to be damaged. By the time the medication stops working adequately, the damage may be irreversible.

A second common error is confusing occupational asthma with work-aggravated asthma. Some workers have pre-existing asthma — unrelated to their job — that is made worse by general workplace conditions such as cold air, physical exertion or non-specific dust. This is clinically different from true occupational asthma, where the workplace exposure is the cause. The distinction matters because work-aggravated asthma does not necessarily require redeployment, while occupational asthma does. Conflating the two can lead to either unnecessary disruption for a worker with aggravated asthma, or inadequate action for a worker with genuine sensitisation.

A third misunderstanding is that RPE provides complete protection and that a worker wearing a respirator can safely continue in the same exposure environment indefinitely. This is false. No RPE provides 100% protection in real workplace conditions, and for a sensitised worker, even marginal exposure is enough to trigger a reaction. The assumption that a mask solves the problem is one of the most common reasons that occupational asthma cases are managed inadequately.

Finally, many workers — and some managers — believe that symptoms only affect people who are somehow susceptible or physically weak, and that a robust worker will not develop sensitisation. Sensitisation is an immune process. It can occur in any individual given sufficient exposure. Prior good health provides no protection. Smokng increases the risk but is not required for sensitisation to occur. The worker who has never had any breathing problems and has worked in the same environment for ten years is not immune — sensitisation can occur at any point during an exposure career, and when it does, it is permanent.

How this article was made. It was drafted with the help of artificial intelligence, then reviewed and approved before publication by Dr. Ackhmez Chuttoo, MD, an occupational health consultant. It is general information about workplace health — not medical advice, and no substitute for speaking to a qualified professional about your own situation. Spotted something wrong? Tell us.

Concerned about your profession’s health risks?

Check my profession’s health risks →